» Articles » PMID: 12133940

Cross-reactive Antigen is Required to Prevent Erosion of Established T Cell Memory and Tumor Immunity: a Heterologous Bacterial Model of Attrition

Overview
Journal J Immunol
Date 2002 Jul 23
PMID 12133940
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Induction and maintenance of T cell memory is critical for the control of intracellular pathogens and tumors. Memory T cells seem to require few "maintenance signals," though often such studies are done in the absence of competing immune challenges. Conversely, although attrition of CD8(+) T cell memory has been characterized in heterologous viral models, this is not the case for bacterial infections. In this study, we demonstrate attrition of T cell responses to the intracellular pathogen Listeria monocytogenes (LM) following an immune challenge with a second intracellular bacterium, Mycobacterium bovis (bacillus Calmette-Guérin, BCG). Mice immunized with either LM or recombinant LM (expressing OVA; LM-OVA), develop a potent T cell memory response. This is reflected by peptide-specific CTL, IFN-gamma production, and frequency of IFN-gamma-secreting T cells to native or recombinant LM Ags. However, when the LM-infected mice are subsequently challenged with BCG, there is a marked reduction in the LM-specific T cell responses. These reductions are directly attributable to the effects on CD4(+) and CD8(+) T cells and the data are consistent with a loss of LM-specific T cells, not anergy. Attrition of the Ag (OVA)-specific T cell response is prevented when LM-OVA-immunized mice are challenged with a subsequent heterologous pathogen (BCG) expressing OVA, demonstrating memory T cell dependence on Ag. Although the reduction of the LM-specific T cell response did not impair protection against a subsequent LM rechallenge, for the first time, we show that T cell attrition can result in the reduction of Ag-specific antitumor (B16-OVA) immunity previously established with LM-OVA immunization.

Citing Articles

XIAP promotes the expansion and limits the contraction of CD8 T cell response through cell extrinsic and intrinsic mechanisms respectively.

Thakker P, Ariana A, Hajjar S, Cai D, Rijal D, Sad S PLoS Pathog. 2023; 19(6):e1011455.

PMID: 37347786 PMC: 10321636. DOI: 10.1371/journal.ppat.1011455.


Past Life and Future Effects-How Heterologous Infections Alter Immunity to Influenza Viruses.

Souquette A, Thomas P Front Immunol. 2018; 9:1071.

PMID: 29872429 PMC: 5972221. DOI: 10.3389/fimmu.2018.01071.


The two faces of heterologous immunity: protection or immunopathology.

Sharma S, Thomas P J Leukoc Biol. 2013; 95(3):405-16.

PMID: 24212098 PMC: 3923083. DOI: 10.1189/jlb.0713386.


Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Campbell J, Trgovcich J, Kincaid M, Zimmerman P, Klenerman P, Sims S J Leukoc Biol. 2012; 92(5):933-7.

PMID: 22730545 PMC: 3476242. DOI: 10.1189/jlb.1211635.


Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

Chen A, Cornberg M, Gras S, Guillonneau C, Rossjohn J, Trees A PLoS Pathog. 2012; 8(4):e1002633.

PMID: 22536152 PMC: 3334890. DOI: 10.1371/journal.ppat.1002633.